Kev kho mob raum cell carcinoma pathology

Kev kho mob ntawm lub raum Cell Carcinoma: Ib Txoj Kev Pom Zoo

Cov lus qhia dav dav no tshawb txog cov kab mob ntawm lub raum cell carcinoma (RCC), delving rau hauv nws ntau yam subtypes, kev kuaj mob, thiab cuam tshuam rau cov tswv yim kho mob. Peb tshuaj xyuas cov yam ntxwv ntawm microscopic, genetic alterations, thiab prognostic yam cuam tshuam nrog RCC, muab kev nkag siab ntxaws rau cov kws kho mob thiab cov kws tshawb fawb.

Nkag siab txog lub raum Cell Carcinoma

Txhais RCC thiab nws cov subtypes

Lub raum cell carcinoma, feem ntau hom mob raum mob cancer, tshwm sim nyob rau hauv ob sab ntawm lub raum tubules. Muaj ntau hom subtypes muaj, txhua tus muaj cov yam ntxwv ntawm pathological thiab kev coj cwj pwm kho mob. Cov no suav nrog cov cell ntshiab RCC (ccRCC), papillary RCC (pRCC), chromophobe RCC (chRCC), thiab lwm yam. Qhov tseeb subtyping yog qhov tseem ceeb rau kev taw qhia Kev kho mob raum cell carcinoma pathology thiab kwv yees kwv yees. Qhov kev faib tawm meej yog nyob ntawm kev soj ntsuam xyuas microscopic thiab immunohistochemical staining, feem ntau xav tau kev txawj ntse hauv genitourinary pathology.

Microscopic Features thiab Diagnostic Criteria

Kev kuaj mob ntawm RCC feem ntau yog ua raws li kev kuaj mob histopathological ntawm cov ntaub so ntswg kuaj tau los ntawm kev kuaj ntshav biopsy lossis phais phais. Cov yam ntxwv tshwj xeeb microscopic, xws li cell morphology, cov yam ntxwv ntawm nuclear, thiab cov qauv kev loj hlob, pab sib txawv ntawm RCC subtypes. Piv txwv li, ccRCC yog tus cwj pwm los ntawm cov cytoplasm ntshiab, thaum pRCC nthuav tawm papillary architecture. Immunohistochemistry plays lub luag haujlwm tseem ceeb hauv kev lees paub qhov kev kuaj mob thiab txheeb xyuas cov subtypes tshwj xeeb, pab kho kom zoo. Kev kho mob raum cell carcinoma pathology kev npaj.

Genetic Alterations thiab Molecular Pathology

Lub luag haujlwm ntawm Genetics hauv RCC Development

Genetic abnormalities ua lub luag haujlwm tseem ceeb hauv kev txhim kho thiab kev loj hlob ntawm RCC. Feem ntau cov kev hloov pauv caj ces feem ntau cuam tshuam nrog von Hippel-Lindau (VHL) qog nqaij hlav qog, tshwj xeeb hauv ccRCC. Lwm cov noob, xws li PBRM1, BAP1, thiab SETD2, kuj nquag hloov pauv hauv RCC subtypes sib txawv. Nkag siab txog cov kev hloov pauv caj ces yog qhov tseem ceeb rau kev tsim kho cov phiaj xwm thiab txhim kho cov txiaj ntsig ntawm tus neeg mob. Cov txheej txheem qib siab molecular, zoo li tiam tom ntej sequencing, yog nce siv los txheeb xyuas cov kev hloov pauv no, qhia rau Kev kho mob raum cell carcinoma pathology mus kom ze.

Qhov cuam tshuam rau Kev Kho Mob Lub Hom Phiaj

Kev txheeb xyuas cov kev hloov pauv caj ces hauv RCC tau ua rau muaj kev txhim kho cov kev kho mob. Piv txwv li, inhibitors ntawm vascular endothelial kev loj hlob yam (VEGF) thiab mammalian lub hom phiaj ntawm rapamycin (mTOR) feem ntau yog siv nyob rau hauv advanced RCC, tshwj xeeb tshaj yog cov uas muaj VHL kev hloov. Cov neeg ua haujlwm tsom no feem ntau qhia cov txiaj ntsig kho mob tseem ceeb thiab txhim kho cov neeg muaj sia nyob. Kev tshawb fawb tsis tu ncua rau hauv molecular underpinnings ntawm RCC txuas ntxiv mus rau txoj hauv kev rau kev kho kom zoo dua qub thiab cov tswv yim kho tus kheej.

Prognostic Factors thiab Treatment Strategies

Predicting Prognosis thiab Kev Xaiv Kev Kho Mob

Ntau yam cuam tshuam rau qhov kev tshwm sim ntawm RCC, nrog rau cov qog qog, qib, thiab subtype. Lub xub ntiag ntawm tus kab mob metastatic cuam tshuam rau cov ciaj sia taus. Pathological nta, xws li qib nuclear thiab necrosis, kuj ua rau muaj kev cuam tshuam txog kev sib kis. Cov ncauj lus kom ntxaws txog kab mob pathological no yog qhov tseem ceeb rau kev coj ua kev txiav txim siab kho mob thiab kho cov txheej txheem kho mob rau tus neeg mob. Kev xaiv ntawm Kev kho mob raum cell carcinoma pathology nyob ntawm qhov kev ntsuas no ntau heev.

Cov kev xaiv kho mob thiab lawv lub hauv paus pathological

Cov tswv yim kho mob rau RCC txawv nyob ntawm theem thiab qib ntawm tus kab mob. Kev phais phais yog qhov kev kho mob tseem ceeb rau hauv cheeb tsam RCC. Rau qib siab lossis metastatic RCC, cov kev kho mob xws li cov neeg ua haujlwm tsom lossis tshuaj tiv thaiv kab mob yog ua haujlwm. Kev xaiv kev kho mob feem ntau yog coj los ntawm cov kab mob pathological, kev hloov pauv caj ces, thiab tus neeg mob tag nrho kev noj qab haus huv. Kev tshawb fawb tsis tu ncua tshawb nrhiav cov txheej txheem kho tshiab, siv peb txoj kev nkag siab ntau ntxiv ntawm cov txheej txheem molecular uas tsav RCC txoj kev loj hlob.

Advanced Techniques hauv RCC Pathology

Immunohistochemistry thiab nws cov ntawv thov

Immunohistochemistry (IHC) yog ib qho cuab yeej tseem ceeb hauv RCC pathology. Cov cim tshwj xeeb, xws li VHL, AMACR, thiab PAX8, yog siv los txheeb xyuas RCC subtypes thiab cais lawv los ntawm lwm cov qog raum. IHC kuj tseem tuaj yeem pab txheeb xyuas qib qog nqaij hlav thiab kwv yees kev kwv yees. Tsis tas li ntawd, IHC ua lub luag haujlwm tseem ceeb hauv kev txheeb xyuas cov hom phiaj kho mob, qhia tus kheej Kev kho mob raum cell carcinoma pathology kev txiav txim siab.

Molecular Pathology Techniques

Advanced molecular cov txheej txheem, xws li cov tiam tom ntej sequencing (NGS) thiab fluorescence nyob rau hauv situ hybridization (FISH), yog nce siv nyob rau hauv RCC pathology. NGS tso cai rau kev nthuav dav genomic profiling, txheeb xyuas ntau yam kev hloov pauv caj ces uas tuaj yeem cuam tshuam kev xaiv kev kho mob thiab kwv yees cov lus teb rau kev kho. FISH tuaj yeem kuaj pom qhov txawv txav ntawm chromosomal, muab kev nkag siab ntxiv rau cov qog nqaij hlav thiab kev kuaj mob.

Cov ntaub ntawv muab ntawm no yog rau kev kawm nkaus xwb thiab tsis yog cov lus qhia kho mob. Rau kev kuaj mob thiab kev kho mob ntawm lub raum cell carcinoma, thov sab laj nrog tus kws kho mob uas tsim nyog.

Yog xav paub ntxiv thiab kev txhawb nqa, xav txog kev mus xyuas lub Shandong Baofa Cancer Research Institute lub vev xaib. Lawv muab cov peev txheej tseem ceeb thiab kev txawj ntse hauv kev kho mob qog noj ntshav.